Reaction
Leukaemia Cutis reporting signals
As of the last recalculation, Leukaemia Cutis appears in 153 FAERS reports alongside 7 co-occurring drug terms. The strongest observed disproportionality signal is BLINATUMOMAB (PRR 216.7).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Blinatumomab | 15 | 216.7 | 217.0 |
| Cladribine | 9 | 135.3 | 135.4 |
| Bendamustine Hydrochloride | 8 | 95.8 | 95.9 |
| Bendamustine Hcl | 9 | 83.8 | 83.9 |
| Pemetrexed | 10 | 67.8 | 67.8 |
| Azacitidine For | 8 | 63.1 | 63.1 |
| Azacitidine | 11 | 54.3 | 54.3 |